Title of article
FGF21 and the Second Coming of PPARγ
Author/Authors
Li Qiang، نويسنده , , Domenico Accili، نويسنده ,
Issue Information
هفته نامه با شماره پیاپی سال 2012
Pages
2
From page
397
To page
398
Abstract
Peptide hormone fibroblast growth factor-21 (FGF21) has insulin-mimetic properties. Dutchak et al. now suggest that FGF21 also acts in an autocrine fashion in adipocytes and is required to mediate effects of the PPARγ agonist class of antidiabetic drugs. Does this new property improve FGF21ʹs fledgling clinical prospects or endorse a clinical resuscitation of PPARγ agonists?
Journal title
CELL
Serial Year
2012
Journal title
CELL
Record number
1021032
Link To Document